Philips continues research efforts with Lenox Hill Hospital

Philips Medical Systems will further its research initiatives with Lenox Hill Hospital.

Philips signed a two-year agreement with the hospital that enhances their partnership of nearly 15 years. The facility is a 652-bed acute-care hospital located on Manhattan's Upper East Side and home to the Lenox Hill Heart and Vascular Institute.

According to Philips, the plan is to co-develop interventional technologies that will deliver vital insight into the heart's anatomy and enable cardiologists to provide more thorough exams, diagnoses and treatment plans for cardiovascular patients.

Researchers will focus on a new image processing algorithm and how it can be used with Philips Allura Xper FD10 cath lab. Philips says the hope is to provide clinicians with enhanced images of the heart, enabling them to see lesions or growths in greater detail. In addition, Philips StentBoost, an interventional tool that allows clinicians to see stents in greater detail, will be evaluated to assess its value for stent placement and gauge its clinical efficacy.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.